Aclarion, Inc. (Nasdaq: ACON, ACONW) has announced that nearly 100 Nociscan procedures have been performed at The London Clinic, one of the United Kingdom's leading private hospitals, indicating increasing integration of the technology into routine clinical practice for evaluating chronic low back pain. The company also released a new video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon and Lead Clinician at The London Spine Clinic, who shares his real-world experience with Nociscan.
Nociscan is a non-invasive diagnostic platform that uses magnetic resonance spectroscopy (MRS) and proprietary augmented intelligence algorithms to identify chemical biomarkers associated with painful discs in the lumbar spine. By providing objective data that complements traditional imaging, Nociscan helps physicians differentiate between painful and non-painful discs, potentially improving surgical outcomes. According to the company, clinical data has demonstrated up to a 97% surgical success rate when all Nociscan-positive discs are treated alongside other diagnostic tools.
Mr. Sutcliffe, who has over 30 years of experience treating spinal conditions, noted in the video that Nociscan offers an additional layer of insight that can inform clinical decisions and enhance physician confidence. “Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain,” he said.
The London Clinic's adoption of Nociscan reflects a broader trend toward objective diagnostic tools for chronic low back pain, a condition affecting approximately 266 million people worldwide. Brent Ness, Chief Executive Officer of Aclarion, emphasized the significance of approaching 100 scans at a leading international center. “This video offers a compelling perspective on how Nociscan is being used in day-to-day clinical practice,” he said. “Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.”
The new physician video is available on Aclarion's website. For more information about Nociscan and to find a Nociscan center, visit the company's site map here. Additional news and updates about Aclarion can be found in the company's newsroom at https://tinyurl.com/aconnewsroom.
